Overview
Colon cancer is cancer that starts in the large intestine
(colon). There is no single cause of colon cancer. Nearly all colon cancers
begin as noncancerous (benign) polyps, which slowly develop into cancer. Many
cases of colon cancer have no symptoms. The following symptoms may indicate
colon cancer abdominal pain and tenderness in the lower abdomen, blood in the
stool, diarrhea, constipation, or other change in bowel habits, narrow stools
and weight loss with no known reason. Treatment includes surgery, radiation
therapy and chemotherapy.
Click here for sample report @ http://www.wiseguyreports.com/sample-request/1555337-colon-cancer-pipeline-review-h1-2017
Report
Highlights
The Pharmaceutical and Healthcare latest pipeline guide Colon
Cancer - Pipeline Review, H1 2017, provides comprehensive information on the
therapeutics under development for Colon Cancer (Oncology), complete with
analysis by stage of development, drug target, mechanism of action (MoA), route
of administration (RoA) and molecule type.
The Colon Cancer (Oncology) pipeline guide also reviews of
key players involved in therapeutic development for Colon Cancer and features
dormant and discontinued projects. The guide covers therapeutics under
Development by Companies /Universities /Institutes, the molecules developed by
Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and
Discovery stages are 1, 12, 35, 4, 168 and 21 respectively. Similarly, the
Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages
comprises 2, 3, 44 and 16 molecules, respectively.
Colon Cancer (Oncology) pipeline guide helps in identifying
and tracking emerging players in the market and their portfolios, enhances
decision making capabilities and helps to create effective counter strategies
to gain competitive advantage. Additionally, various dynamic tracking processes
ensure that the most recent developments are captured on a real time basis.
Major Scope of the report:
- The pipeline guide provides a snapshot of the global
therapeutic landscape of Colon Cancer (Oncology).
- The pipeline guide reviews pipeline therapeutics for Colon Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Colon Cancer (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide reviews pipeline therapeutics for Colon Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Colon Cancer (Oncology) therapeutics and enlists all their major and minor projects.
Table of Contents
Introduction 7
Colon Cancer - Overview 8
Colon Cancer - Therapeutics Development 9
Colon Cancer - Therapeutics Assessment 42
Colon Cancer - Companies Involved in Therapeutics Development 64
Colon Cancer - Drug Profiles 136
Colon Cancer - Dormant Projects 692
Colon Cancer - Discontinued Products 703
Colon Cancer - Product Development Milestones 704
Appendix 714
Colon Cancer - Overview 8
Colon Cancer - Therapeutics Development 9
Colon Cancer - Therapeutics Assessment 42
Colon Cancer - Companies Involved in Therapeutics Development 64
Colon Cancer - Drug Profiles 136
Colon Cancer - Dormant Projects 692
Colon Cancer - Discontinued Products 703
Colon Cancer - Product Development Milestones 704
Appendix 714
List of Tables
Number of Products under Development for Colon Cancer, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..2), H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..3), H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..4), H1 2017
Number of Products under Development for Colon Cancer, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..2), H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..3), H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..4), H1 2017
Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1555337-colon-cancer-pipeline-review-h1-2017
About Us
Wise Guy
Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium
progressive statistical surveying, market research reports, analysis &
forecast data for industries and governments around the globe. Wise Guy Reports
understand how essential statistical surveying information is for your
organization or association. Therefore, we have associated with the top
publishers and research firms all specialized in specific domains, ensuring you
will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner
Relations & Marketing Manager
Ph:
+1-646-845-9349 (US)
Ph: +44 208
133 9349 (UK)
No comments:
Post a Comment